MORGAN STANLEY PLC/CALL/PFIZER INC/39.5/0.1/17.01.25 Share Price

Warrant

DE000MB333B7

Real-time Bid/Ask 16:21:19 01/07/2024 BST
0.023 EUR / 0.04 EUR +39.13% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/39.5/0.1/17.01.25
Current month-11.54%
1 month-14.81%
Date Price Change
01/07/24 0.023 0.00%
28/06/24 0.023 0.00%
27/06/24 0.023 +9.52%
26/06/24 0.021 +5.00%
25/06/24 0.02 0.00%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 02:26 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB333B
ISINDE000MB333B7
Date issued 01/02/2023
Strike 39.5 $
Maturity 17/01/2025 (200 Days)
Parity 10 : 1
Emission price 0.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.85
Lowest since issue 0.017
Spread 0.017
Spread %42.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98 USD
Average target price
31.92 USD
Spread / Average Target
+14.07%
Consensus